The balance between apoptosis ("programmed cell death") and autophagy ("programmed cell survival") is important in tumor development and response to therapy.
INTRODUCTION
Autophagy maintains cellular viability in the setting of various stressors (1, 2) .
Mediated via the lysosomal degradation pathway, autophagy recycles cellular proteins and organelles to ensure cell survival. Apoptosis is a process through which superfluous, effete, ectopic, aged, damaged, unattached, or mutated cells are eliminated (3) . The balance between autophagy and apoptosis is regulated by various cell signals, and crosstalk between these pathways determines cell fate in the setting of stress (4, 5) . In addition to their role in respectively suppressing or promoting tumorigenesis, apoptosis and autophagy contribute to the sensitivity or resistance of tumors to various therapies (6, 7) . A more detailed understanding of the mechanisms by which autophagy interfaces with apoptotic mechanisms will enhance our understanding of cancer biology (8, 9) . p53 and associated molecular pathways are the most commonly mutated in human cancers, regulating apoptosis, autophagy, metabolism, and persistence in hypoxic environments (10) . p53 itself promotes apoptosis by both transcription-dependent and independent mechanisms (11) (12) (13) . In contrast, p53 regulates autophagy in a dual fashion whereby the pool of cytoplasmic p53 protein represses autophagy in a transcriptionindependent fashion (14) , and the pool of nuclear p53 stimulates autophagy in a transcription-dependent fashion (15, 16) . These studies suggest that the function of p53 in the regulation of autophagy (and cell fate) is tightly controlled by its subcellular localization (17) .
High mobility group box 1 (HMGB1), a highly conserved nuclear protein, acts as a chromatin-binding factor that bends DNA and promotes access to transcriptional protein complexes. In addition to its nuclear role, HMGB1 also functions as an extracellular Author Manuscript Published OnlineFirst on February 16, 2012 ; DOI: 10.1158/0008-5472. CAN-11-2291 signaling molecule during inflammation, cell differentiation, cell migration, wound healing, and tumor progression (18, 19) . Our recent studies demonstrate that endogenous and exogenous HMGB1 are critical regulators of autophagy (20) (21) (22) (23) (24) . Endogenous HMGB1 promotes autophagy by both transcription-dependent and independent mechanisms (22, 23) . Cytoplasmic HMGB1 is a Beclin 1-binding protein, which sustains Beclin 1-PtdIns3KC3 complex activation during upregulation of autophagy (23, 25) .
Additionally, exogenous HMGB1 promotes autophagy in tumor cells through interactions with the receptor for advanced glycation end products (RAGE) (26, 27) .
The relationship between HMGB1 and p53 in the regulation of autophagy was previously unknown. Here heat-inactivated fetal bovine serum in a humidified incubator with 5% CO 2 and 95% air.
All cell lines were characterized and confirmed according to ATCC instructions.
Biolayer interferometry
All measurements were made using a FortéBio Octet QK platform and default settings for the sample stage orbital rate (1000 rpm) and temperature (30 °C) were used.
Streptavadin Biosensors: Prior to assay, p53 or HMGB1 was biotinylated using a 5:1 biotin:protein ratio using the EZ-Link LC-LC (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. Unincorporated biotins were removed using Zeba desalt columns (Pierce, Rockford, IL, USA) according to the manufacturer's instructions. 
Survival clonogenic assay
Long-term cell survival was monitored in a colony formation assay. In brief, 1000 cells were treated with individual chemotherapeutic drugs for 24 h and plated into 24 well plates. Colonies were visualized by crystal violet staining after 2 weeks as previously described (28) . 
RESULTS

HMGB1 binds p53 within the nucleus and cytosol
Although interactions between HMGB1 and p53 have been previously well defined in the nucleus, these in vitro assays were only able to demonstrate an interaction in the presence of DNA (29) . We evaluated the direct interaction between HMGB1 and p53 using biolayer interferometry (30) . We coupled recombinant HMGB1 to an amine reactive biosensor using an amine linking reagent, introduced recombinant p53 to determine the association constant, and then washed off the p53 to determine the dissociation constant. We found in this cell free assay that in the absence of DNA, the K D for HMGB1 and p53 binding was 1.15 ×10 -9 ± 0.03 M (Supplemental Table 1 ).
Similarly, when p53 was coupled to the biosensor and recombinant HMGB1 was introduced in solution, the K D was determined to be 1.83 × 10 -9 ± 0.44 M (Supplemental Table 1 ). Furthermore, oxidation of HMGB1 with H 2 O 2 had a minimal effect on the affinity with p53 whereas reduction of p53 using tris 2-carboxyehtyl phosphine (TCEP) abrogated interaction with HMGB1 (Supplemental Table 2 ). Others have demonstrated that the A box of HMGB1 interacts with p53 (31) . Thus, we coupled the A or B box of HMGB1 to the biosensor and then determined the affinity for p53. We found that the A box had a slightly higher affinity for p53 than the B box with calculated K D 's of 6.38 × M respectively (Supplemental Table 3 ).
To validate these findings using the amine reactive biosensors in the analysis of p53/HMGB1 interactions, we performed the assay with known targets and nonspecific targets for these respective proteins. M for murine double minute-2 (Mdm2) which binds and ubiquinates p53, but did not bind to BSA (Supplemental Table 4 ). To further confirm the interaction between p53 and HMGB1 using biolayer interferometry we biotinylated HMGB1 and p53, coupled the biotinylated protein to streptavidin biosensors and then determined the affinity for the target protein.
The association and dissociation curves for biotinylated p53 and a dilution series of HMGB1 ( Figure 1A ) and biotinylated HMGB1 and a dilution series of p53 ( Figure 1B) were used to determine the global fit for the equilibrium dissociation constants. Table 5 ).
To determine the dynamic interaction between HMGB1 and p53 in vitro in response to cell stress, we starved HCT116 cells to enhance levels of autophagy. We then immunoprecipitated whole cell lysates with HMGB1 antibody and probed for p53 by western blot. We found increased complex formation between HMGB1 and p53 following Hank's balanced salt solution (HBSS)-induced starvation by immunoprecipitation assay ( Figure 1C) . Moreover, immunoprecipitation of nuclear and cytosolic extracts revealed HMGB1 and p53 binding in both subcellular compartments, especially in the nucleus following HBSS-induced starvation ( Figure 1D ). Furthermore, confocal microscopy revealed significant colocalization of HMGB1 with p53 within the nucleus and cytosol following HBSS-induced starvation ( Figure 1E ).
Loss of p53 enhances autophagy and promotes cytosolic HMGB1 translocation
Others have shown that knockout of p53 increases starvation induced autophagy 
p53-mediated expression of DRAM and ULK1 is HMGB1-independent
Damage-regulated autophagy modulator (DRAM) is a p53 target gene encoding a lysosomal protein that promotes autophagy (15) . Unc-51-like kinase 1 (ULK1) is important for induction of autophagy and is a direct target of p53 (16) . To explore whether the interaction of HMGB1/p53 within the nucleus influences p53-dependent expression of DRAM and ULK1, we performed a western blot analysis of p53 -/-and HMGB1 knockdown HCT116 cells. Consistent with previous studies (15, 16) , DRAM and ULK1 were induced by DNA damaging agents such as adriamycin ("ADM") and etoposide ("ETO") ( Figure 4A-B) . Knockout of p53, but not knockdown of HMGB1, impaired upregulation of DRAM and ULK1 (Figure 4A-B) , suggesting that p53-mediated expression of DRAM and ULK1 during DNA damage is HMGB1-independent.
HMGB1-mediated autophagy promotes cell survival during p53-dependent apoptosis
There is a tight and complex relationship between apoptosis and autophagy (4), with both processes increasing during periods of cellular stress. Autophagy plays a dual role in the regulation of p53-dependent apoptosis, as it is reported to both promote and inhibit cellular death (15, 16, 35) (Figure 5B and 5C) . Moreover, knockdown of HMGB1 increased Bax translocation from the cytosol to mitochondria, cytochrome c release from mitochondria, and caspase-9 activation in p53 -/-cells ( Figure 5D-E Figure 5G ). These findings suggest that HMGB1-mediated autophagy promotes cell survival during p53-dependent apoptosis.
HMGB1 regulates p62 degradation during autophagy
p62 is a multifunctional protein that regulates cell proliferation, differentiation, apoptosis, inflammation, autophagy and obesity (37, 38) . p62 binds protein aggregates and is degraded by autophagy (39) . In contrast, p62 upregulation is observed with increased endoplasmic reticulum (ER) stress (40, 41) , although ER stress triggers LC3 conversion and autophagy (41, 42) . ER stress and upregulation of p62 are common in human tumors (38, 43, 44) . To explore whether HMGB1 regulates ER stress-mediated p62 expression, we treated cells with thapsigargin which induces ER stress ( Figure S1D ).
Knockdown of HMGB1 by shRNA inhibited thapsigargin induced upregulation of ER stress markers (e.g., calnexin and CHOP), LC3-II and p62 expression. In contrast, knockdown of HMGB1 limited starvation-induced p62 degradation (Figure 3A) . These findings suggest that HMGB1 not only regulates p62 expression in response to ER stress, but also p62 degradation during autophagy. HMGB1 and p53 sequester the binding partner within the nucleus and that without a binding partner, HMGB1 or p53 can more readily translocate to the cytosol. As a transcription factor, p53 activates genes that induce apoptosis, permanent cell cycle arrest (senescence) or autophagy (e.g. DRAM and ULK1) (15, 16) . As a cytoplasmic protein, p53 mediates tonic inhibition of autophagy (14) and the induction of apoptosis, the latter presumably through coupling with the PUMA/Bax-mediated mitochondrial pathway (11, 13) . In contrast, both nuclear and cytoplasmic HMGB1 are positive regulators of autophagy. Cytoplasmic HMGB1 interacts with Beclin 1, and localizes Beclin 1 to autophagosomes (23) . We demonstrated that loss of p53 increases interactions between 
HMGB1 and Beclin 1, suggesting that p53 is a negative regulator of HMGB1/Beclin 1 interactions. On the other hand, as a transcription factor, HMGB1 regulates the expression of the small heat shock protein 27 (Hsp27 or HSPB1), which we have shown regulates the cytoskeleton as well as the dynamics of autophagy and mitophagy(22).
HMGB1 does not, however, influence p53-dependent expression of DRAM and ULK1 during autophagy. In contrast, HMGB1 is required for induction of autophagy during knockout or pharmacological inhibition of p53. These studies suggest that HMGB1 regulates the cytoplasmic but not the nuclear functions of p53 during autophagy.
Additionally, we demonstrate that HMGB1-mediated autophagy contributes to apoptosis resistance in p53 -/-cancer cells. As a tumor suppressor, p53 limits tumor cell growth by inducing cell cycle arrest and apoptosis in response to cellular stress such as DNA damage and oncogene activation. The inhibition of autophagy is an attractive therapeutic option, as there is increasing evidence suggesting that inhibiting autophagy in cancer cells is associated with increased apoptotic cell death (9) . Others have suggested, that in the absence of apoptosis, autophagic cell death can be an alternative form of cell death by excessive self-digestion (46) . However, increasing studies indicate that the accumulation of autophagosomes in dying cells is not the important effector mechanism of cell death (47) . Indeed, autophagy is a response to stress associated with cell death whereby it functions primarily as a cell survival mechanism (1). In this sense, the term "autophagic cell death" may be inappropriate (47) , whereas autophagy occurring prior to various forms of cell death (apoptosis, necroptosis, necrosis) may be a better way to consider how these events relate to one other. We demonstrated that HMGB1 is required for autophagy in p53 
